Literature DB >> 18565634

A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes.

Paul Mendes1, Sunil Kapur, Jingzhu Wang, Shixia Feng, Hans Roethig.   

Abstract

Rationale. To date no state-of-the-art clinical study has been conducted to address the question as to whether switching to lower tar cigarettes reduces exposure to smoke constituents in humans. Methods. Randomized, controlled, forced switching study in 225 adult smokers of full flavor Marlboro (MFF) cigarettes for 8 days with a 24-week follow-up. Subjects smoked MFF (a 15-mg Federal Trade Commission (FTC) tar cigarette) at baseline and were randomized to smoke 11-mg Marlboro Lights (ML) or 6-mg Marlboro Ultra Lights (MUL) cigarettes. Biomarkers of exposure to nicotine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), pyrene, CO, benzene, acrolein, and mutagenic substances were measured. Results. In the short-term phase, switching from MFF to ML showed statistically significant decreases in nicotine exposure (-13%) and non-significant increases in CO exposure (+6%), while switching from MFF to MUL showed statistically significant decreases in nicotine (-27%) and CO (-13%) exposure. Both nicotine and CO biomarkers trended similarly in the 24-week follow-up as in the short-term phase. The other biomarkers of cigarette smoke constituents followed the same trend as nicotine at the end of the 24-week follow-up. Conclusions. Switching smokers to lower FTC tar yield cigarettes, on average, reduces nicotine and other biomarkers considered surrogates of tar exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565634     DOI: 10.1016/j.yrtph.2008.04.014

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  12 in total

Review 1.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

2.  Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.

Authors:  Stephen S Hecht; Jian-Min Yuan; Dorothy Hatsukami
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

3.  gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products.

Authors:  Anthony P Albino; Ellen D Jorgensen; Patrick Rainey; Gene Gillman; T Jeffrey Clark; Diana Gietl; Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Mutat Res       Date:  2009-07-08       Impact factor: 2.433

Review 4.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 5.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 6.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers.

Authors:  Steven G Carmella; Menglan Chen; Shaomei Han; Anna Briggs; Joni Jensen; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

Review 8.  Tobacco harm reduction: Past history, current controversies and a proposed approach for the future.

Authors:  Dorothy K Hatsukami; Dana M Carroll
Journal:  Prev Med       Date:  2020-04-23       Impact factor: 4.018

Review 9.  Interventions to reduce harm from continued tobacco use.

Authors:  Nicola Lindson-Hawley; Jamie Hartmann-Boyce; Thomas R Fanshawe; Rachna Begh; Amanda Farley; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

10.  Menthol's potential effects on nicotine dependence: a tobacco industry perspective.

Authors:  Valerie B Yerger
Journal:  Tob Control       Date:  2011-05       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.